Research Topics
Species | Jivko KamarashevSummaryAffiliation: University Hospital Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Lymphogranuloma venereum in Zurich, Switzerland: Chlamydia trachomatis serovar L2 proctitis among men who have sex with menJivko Kamarashev
Department of Dermatology, University Hospital, Zurich, Switzerland
Swiss Med Wkly 140:209-12. 2010..Whereas until 2003 Lymphogranuloma venereum (LGV) was rare in industrialised countries, there have been increasing reports of cases of LGV proctitis in men having sex with men (MSM) over the last six years in Europe, America and Australia...- Symplastic glomus tumor - a rare but distinct benign histological variant with analogy to other 'ancient' benign skin neoplasmsJivko Kamarashev
Department of Dermatology, University Hospital, Zurich, Switzerland
J Cutan Pathol 36:1099-102. 2009..Even prominent cellular atypia and nuclear pleomorphism in a glomus tumor as in our case is not a marker of malignancy in the absence of additional criteria... 
Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformationJivko Kamarashev
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
Int J Dermatol 46:930-5. 2007..In order to better understand the dynamics of the disease and the prognostic implications in patients who progress, we studied the duration of each stage and the time at which blast transformation occurred...- Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the bmi-1 and ras oncogenes in disease progressionChunlei Zhang
Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
Hum Pathol 38:995-1002. 2007..Thus, cutaneous T-cell lymphoma cells show changes in oncogene and tumor suppressor gene expression that increase proliferation... - CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotypeMirjana Urosevic
Department of Dermatology, University Hospital Zurich, Zurich 8091, Switzerland
Hum Pathol 36:1020-4. 2005..MxA protein, representing the surrogate marker for lesional type I interferon activity, was expressed in 4 of 5 evaluated cases. Our findings further substantiate the putative pDC origin of CD4+CD56+ HNs... - Constitutional intraepidermal ascent of melanocytes: a potential pitfall in the diagnosis of melanocytic lesionsKatrin Kerl
Department of Dermatology, University Hospital of Zurich, CH 8091 Zurich, Switzerland
Arch Dermatol 148:235-8. 2012..We discuss the value of TEM for the diagnosis of melanocytic tumors in a young patient previously diagnosed as having 11 cutaneous melanomas... - Spitzoid melanoma and micrometastases in two lymph node regions: a critical situationAlexander A Navarini
Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland
Eur J Dermatol 21:229-33. 2011..Treatment decisions for atypical Spitz tumors are a major medical and ethical challenge due to the limited available data... - Trauma as triggering factor for development of melanocytic neviAlexander A Navarini
Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, Zurich, Switzerland
Dermatology 220:291-6. 2010..We conclude that in predisposed patients, the trigger for eruptive nevi can be reduced to a simple localized minor trauma... - Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2Mirjana Urosevic
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
Blood 103:1796-8. 2004..Together with the expression of IL-10, HLA-G might be one of the factors accounting for the evasion of immunosurveillance, thus contributing to aggressive phenotype of these lymphoma entities... - Primary Cutaneous CD8+ Small- to Medium-Sized Lymphoproliferative Disorder in Extrafacial Sites: Clinicopathologic Features and Concept on Their ClassificationWerner Kempf
Kempf und Pfaltz Histologische Diagnostik, Zurich, Switzerland Department of Dermatology, University Hospital, Zurich, Switzerland Sikl s Department of Pathology, Charles University, Medical Faculty Hospital, Pilsen, Czech Republic Dermatology Practice, Uster, Switzerland Department of Dermatology, University Hospital Munster, Munster, Germany
Am J Dermatopathol 35:159-66. 2013.... 
RASopathic skin eruptions during vemurafenib therapyJeannine D Rinderknecht
Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
PLoS ONE 8:e58721. 2013..Cutaneous side effects are frequent. This single-center observational study investigates clinical and histological features of these class-specific cutaneous adverse reactions...- T cell-mediated acute localized exanthematous pustulosis caused by finasterideSandra Tresch
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
J Allergy Clin Immunol 129:589-94. 2012..Within 4 weeks after withdrawal of finasteride, the rash resolved without any specific therapy. Transient discrete residual hyperpigmentation and scaling were present. The patient refused an oral provocation challenge... - Mitogen-activated protein/extracellular signal-regulated kinase kinase inhibition results in biphasic alteration of epidermal homeostasis with keratinocytic apoptosis and pigmentation disordersKarin Schad
University Hospital Zurich, Department of Dermatology, Zurich, Switzerland
Clin Cancer Res 16:1058-64. 2010..AZD6244 blocks MEK1/2, inhibiting ERK phosphorylation. We focus on associated cutaneous toxicity and we attempt to understand the underlying pathophysiology and design treatment strategies... - Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides?Reinhard Dummer
Department of Dermatology, University Hospital, Gloriastrasse 31, CH 8091 Zurich, Switzerland
Arch Dermatol 138:199-203. 2002..To evaluate the clinical and prognostic features in primary cutaneous CD8+ T-cell lymphomas, which are rare and considered to be aggressive cutaneous lymphoproliferative disorders... - Trichophyton rubrum-induced Majocchi's Granuloma in a heart transplant recipient. A therapeutic challengeUrs C Steiner
Department of Dermatology, University Hospital, Zurich, Switzerland
J Dermatol Case Rep 6:70-2. 2012..Itraconazole is an anti-fungal compound used for the treatment of infections of the skin, nails and mucous membranes... - Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cellsChun-lei Zhang
Department of Dermatology, University Hospital of Zurich, , Switzerland
J Pathol 200:249-54. 2003..Overexpression of Mcl-1 and synthesis of non-functional Bax may be responsible for the resistance of CTCL cells to the anti-cancer drugs chlorambucil and sulindac... - Treatment of vulvar Paget disease with topical imiquimod: a case report and review of the literatureLaurence Feldmeyer
Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland
J Dermatol Case Rep 5:42-6. 2011..Surgery is considered as the gold standard therapy. In the last years, the topical use of imiquimod cream in the treatment of this condition has been reported... - Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine APietro E Cippà
Institute of Physiology, University of Zurich, Zurich, Switzerland
Apoptosis 18:315-23. 2013..The increased efficacy of Bcl-2 inhibitors in combination with cyclosporine A might be relevant to exploit their anti-neoplastic and immuno-modulatory properties... - Fascin expression in CD30-positive cutaneous lymphoproliferative disordersWerner Kempf
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA 02215, USA
J Cutan Pathol 29:295-300. 2002..Currently there is no marker to predict the development of systemic lymphomas in patients with LyP. Fascin, an actin bundling protein, has recently been shown to be a unique marker found in almost 100% of classical HL... - Immunotherapy for murine K1735 melanoma: combinatorial use of recombinant adenovirus expressing CD40L and other immunomodulatorsIsabelle Peter
Institute of Molecular Biology, University of Zurich, Winterthurerstrasse 190, CH 8057 Zurich, Switzerland
Cancer Gene Ther 9:597-605. 2002..These results propose that a combination of CD40L plus IL-2 has an improved efficacy over the use of single agents when applied for direct in situ therapy or vaccination therapy...